Repros hires Donald Tredway as CMO
This article was originally published in Scrip
Focused on developing oral small molecule drugs for reproductive disorders, Repros Therapeutics has appointed Dr Donald Tredway chief medical officer. Dr Tredway was vice-president and global head of the fertility and endocrinology GCDU for EMD Serono until July 2009, when he retired. He has subsequently been acting as a regulatory and clinical development consultant to several pharmaceutical companies.